Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.

Jenkinson HA, Siroy AE, Choksi A.

J Drugs Dermatol. 2017 Oct 1;16(10):1050-1052.

PMID:
29036262
2.

Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.

Kim DW, Haydu LE, Joon AY, Bassett RL Jr, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA.

Cancer. 2017 Apr 15;123(8):1372-1381. doi: 10.1002/cncr.30463. Epub 2016 Dec 2.

3.

Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.

Roszik J, Haydu LE, Hess KR, Oba J, Joon AY, Siroy AE, Karpinets TV, Stingo FC, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Chen K, Forget MA, Haymaker CL, Chen JQ, Meric-Bernstam F, Eterovic AK, Shaw KR, Mills GB, Gershenwald JE, Radvanyi LG, Hwu P, Futreal PA, Gibbons DL, Lazar AJ, Bernatchez C, Davies MA, Woodman SE.

BMC Med. 2016 Oct 25;14(1):168.

4.

Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.

Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG.

Hum Pathol. 2017 Jan;59:48-54. doi: 10.1016/j.humpath.2016.09.010. Epub 2016 Sep 22.

PMID:
27666765
5.

Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.

Roszik J, Wu CJ, Siroy AE, Lazar AJ, Davies MA, Woodman SE, Kwong LN.

Sci Rep. 2016 Jan 20;6:19649. doi: 10.1038/srep19649.

6.

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma.

Sholl LM, Andea A, Bridge JA, Cheng L, Davies MA, Ehteshami M, Gangadhar TC, Kamel-Reid S, Lazar A, Raparia K, Siroy A, Watson KL; Members of Cancer Biomarker Reporting Committee, College of American Pathologists.

Arch Pathol Lab Med. 2016 Apr;140(4):355-7. doi: 10.5858/arpa.2015-0278-CP. Epub 2015 Sep 4. No abstract available.

PMID:
26340412
7.

The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD.

Sun J, Siroy A, Lokareddy RK, Speer A, Doornbos KS, Cingolani G, Niederweis M.

Nat Struct Mol Biol. 2015 Sep;22(9):672-8. doi: 10.1038/nsmb.3064. Epub 2015 Aug 3.

8.

Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.

Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT.

J Cutan Pathol. 2015 May;42(5):308-17. doi: 10.1111/cup.12481. Epub 2015 Mar 24.

PMID:
25754356
9.

Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.

Bucheit AD, Chen G, Siroy A, Tetzlaff M, Broaddus R, Milton D, Fox P, Bassett R, Hwu P, Gershenwald JE, Lazar AJ, Davies MA.

Clin Cancer Res. 2014 Nov 1;20(21):5527-36. doi: 10.1158/1078-0432.CCR-14-1027. Epub 2014 Aug 27.

10.

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.

Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA.

J Invest Dermatol. 2015 Feb;135(2):508-515. doi: 10.1038/jid.2014.366. Epub 2014 Aug 22.

11.

An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity.

Danilchanka O, Sun J, Pavlenok M, Maueröder C, Speer A, Siroy A, Marrero J, Trujillo C, Mayhew DL, Doornbos KS, Muñoz LE, Herrmann M, Ehrt S, Berens C, Niederweis M.

Proc Natl Acad Sci U S A. 2014 May 6;111(18):6750-5. doi: 10.1073/pnas.1400136111. Epub 2014 Apr 21.

12.

MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer.

Siroy A, Abdul-Karim FW, Miedler J, Fong N, Fu P, Gilmore H, Baar J.

Hum Pathol. 2013 Oct;44(10):2159-66. doi: 10.1016/j.humpath.2013.04.010. Epub 2013 Jul 8.

13.

Updating and curating metabolic pathways of TB.

Slayden RA, Jackson M, Zucker J, Ramirez MV, Dawson CC, Crew R, Sampson NS, Thomas ST, Jamshidi N, Sisk P, Caspi R, Crick DC, McNeil MR, Pavelka MS, Niederweis M, Siroy A, Dona V, McFadden J, Boshoff H, Lew JM.

Tuberculosis (Edinb). 2013 Jan;93(1):47-59. doi: 10.1016/j.tube.2012.11.001. Epub 2013 Feb 1. Review.

14.

A novel approach: chest wall cyst excised by MIS.

AlJamal YN, Siroy AE, Farley DR.

J Surg Case Rep. 2013 Sep 26;2013(9). pii: rjt085. doi: 10.1093/jscr/rjt085.

15.

Metastatic Crohn disease: a rare cutaneous entity.

Siroy A, Wasman J.

Arch Pathol Lab Med. 2012 Mar;136(3):329-32. doi: 10.5858/arpa.2010-0666-RS.

PMID:
22372910
16.

Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.

Catel-Ferreira M, Coadou G, Molle V, Mugnier P, Nordmann P, Siroy A, Jouenne T, Dé E.

J Antimicrob Chemother. 2011 Sep;66(9):2053-6. doi: 10.1093/jac/dkr267. Epub 2011 Jun 23.

PMID:
21705362
17.

Primary melanoma of the bladder.

Siroy AE, MacLennan GT.

J Urol. 2011 Mar;185(3):1096-7. doi: 10.1016/j.juro.2010.12.004. Epub 2011 Jan 21. No abstract available.

PMID:
21256523
18.

Membrane proteomes of Pseudomonas aeruginosa and Acinetobacter baumannii.

Dé E, Cosette P, Coquet L, Siroy A, Alexandre S, Duncan A, Naudin B, Rihouey C, Schaumann A, Junter GA, Jouenne T.

Pathol Biol (Paris). 2011 Dec;59(6):e136-9. doi: 10.1016/j.patbio.2009.10.005. Epub 2009 Nov 25. Review.

PMID:
19942379
19.

Rv1698 of Mycobacterium tuberculosis represents a new class of channel-forming outer membrane proteins.

Siroy A, Mailaender C, Harder D, Koerber S, Wolschendorf F, Danilchanka O, Wang Y, Heinz C, Niederweis M.

J Biol Chem. 2008 Jun 27;283(26):17827-37. doi: 10.1074/jbc.M800866200. Epub 2008 Apr 22.

20.

Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.

DeWitt CA, Siroy AE, Stone SP.

J Am Acad Dermatol. 2007 Mar;56(3):500-5. Epub 2006 Dec 12.

PMID:
17166623
21.

Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain.

Siroy A, Cosette P, Seyer D, Lemaître-Guillier C, Vallenet D, Van Dorsselaer A, Boyer-Mariotte S, Jouenne T, Dé E.

J Proteome Res. 2006 Dec;5(12):3385-98.

PMID:
17137340
22.

Identification of an OprD homologue in Acinetobacter baumannii.

Dupont M, Pagès JM, Lafitte D, Siroy A, Bollet C.

J Proteome Res. 2005 Nov-Dec;4(6):2386-90.

PMID:
16335991
23.

Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.

Siroy A, Molle V, Lemaître-Guillier C, Vallenet D, Pestel-Caron M, Cozzone AJ, Jouenne T, Dé E.

Antimicrob Agents Chemother. 2005 Dec;49(12):4876-83.

Supplemental Content

Support Center